QL
ALNY icon

Quarry LP’s Alnylam Pharmaceuticals ALNY Stock Holding History

Quarry LP’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$191K Sell
634
-332
-34% -$100K 0.02% 324
2026
Q1 		$320K Buy
966
+822
+571% +$280K 0.06% 227
2025
Q4 		$57.3K Buy
144
+123
+586% +$54.4K 0.01% 615
2025
Q3 		$9.58K Buy
+21
New +$8.55K ﹤0.01% 1689
2024
Q3 		– Sell
-224
Closed -$54.4K – 1608
2024
Q2 		$54.4K Sell
224
-776
-78% -$123K 0.02% 609
2024
Q1 		$149K Buy
+1,000
New +$167K 0.03% 199

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quarry LP's ALNY Position: Q2 2026 in Review

Quarry LP reduced its Alnylam Pharmaceuticals (ALNY) stake by 34% in Q2 2026, selling an estimated $100K and leaving 634 shares worth $191K. The position accounts for 0.02% of the portfolio, ranked #324.

Quarry LP first reported a position in ALNY in Q1 2024 and has held it in 6 quarters since. The position peaked at $320K in Q1 2026. 785 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Quarry LP held 634 shares of Alnylam Pharmaceuticals worth $191K as of Q2 2026.
  • Quarry LP sold 332 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $100K.
  • Alnylam Pharmaceuticals made up 0.02% of Quarry LP's portfolio in Q2 2026, its #324 holding.
  • Quarry LP first reported a position in Alnylam Pharmaceuticals in Q1 2024 and has held it in 6 quarters since.
  • Quarry LP's Alnylam Pharmaceuticals position peaked at $320K in Q1 2026.
  • 785 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.